Gabapentin and venlafaxine reduce pain in a patient with somatic symptom disorder.
作者信息
Shebak Shady S
机构信息
Carilion Clinic, Virginia Tech Carilion School of Medicine, Roanoke, Virginia.
出版信息
Prim Care Companion CNS Disord. 2014 Jul 31;16(4). doi: 10.4088/PCC.14l01632. eCollection 2014.
Abstract
摘要
相似文献
1
Gabapentin and venlafaxine reduce pain in a patient with somatic symptom disorder.加巴喷丁和文拉法辛可减轻一名躯体症状障碍患者的疼痛。
Prim Care Companion CNS Disord. 2014 Jul 31;16(4). doi: 10.4088/PCC.14l01632. eCollection 2014.
2
Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain.评价围手术期应用文拉法辛或加巴喷丁对急性和慢性乳腺癌根治术后疼痛的疗效。
Clin J Pain. 2010 Jun;26(5):381-5. doi: 10.1097/AJP.0b013e3181cb406e.
3
Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.六种抗抑郁药和抗惊厥药治疗糖尿病性神经痛的疗效和安全性比较：网络荟萃分析。
Pain Physician. 2013 Nov-Dec;16(6):E705-14.
4
Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety in patients with generalized anxiety disorder.文拉法辛缓释片对广泛性焦虑症患者焦虑的躯体和精神症状疗效的汇总分析
Depress Anxiety. 2004;19(2):127-32. doi: 10.1002/da.10141.
5
Treating empty nose syndrome as a somatic symptom disorder.将空鼻综合征视为躯体症状障碍进行治疗。
Gen Hosp Psychiatry. 2015 May-Jun;37(3):273.e9-10. doi: 10.1016/j.genhosppsych.2015.02.005. Epub 2015 Feb 25.
6
Efficacy and tolerability of venlafaxine extended release in patients with major depressive disorder.文拉法辛缓释剂治疗重性抑郁障碍的疗效和耐受性。
Psychiatr Danub. 2010 Sep;22(3):413-7.
7
Gabapentin withdrawal syndrome in the presence of a taper.在逐渐减量过程中出现的加巴喷丁戒断综合征。
Bipolar Disord. 2005 Jun;7(3):302-4. doi: 10.1111/j.1399-5618.2005.00200.x.
8
Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial.度洛西汀、文拉法辛缓释剂与安慰剂对照试验中成年广泛性焦虑症患者心理和躯体症状的改善情况研究
Psychol Med. 2009 Feb;39(2):267-76. doi: 10.1017/S0033291708003401. Epub 2008 May 19.
9
A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure.一名急性肾衰竭患者出现加巴喷丁相关可逆性听力损失的疑似病例。
Clin Ther. 2008 Sep;30(9):1681-4. doi: 10.1016/j.clinthera.2008.09.004.
10
Gabapentin and posttraumatic stress disorder.加巴喷丁与创伤后应激障碍
Ann Pharmacother. 2003 May;37(5):664-6. doi: 10.1345/aph.1C082.
本文引用的文献
1
Alpha 2 Delta (α(2)δ) Ligands, Gabapentin and Pregabalin: What is the Evidence for Potential Use of These Ligands in Irritable Bowel Syndrome.α2δ配体、加巴喷丁和普瑞巴林：这些配体在肠易激综合征中潜在应用的证据是什么。
Front Pharmacol. 2011 Jun 9;2:28. doi: 10.3389/fphar.2011.00028. eCollection 2011.
2
Gabapentin reduces rectal mechanosensitivity and increases rectal compliance in patients with diarrhoea-predominant irritable bowel syndrome.加巴喷丁可降低腹泻型肠易激综合征患者的直肠机械敏感性并提高直肠顺应性。
Aliment Pharmacol Ther. 2005 Nov 15;22(10):981-8. doi: 10.1111/j.1365-2036.2005.02685.x.
3
Efficacy of venlafaxine for the long term treatment of chronic pain with associated major depressive disorder.文拉法辛用于长期治疗伴有重度抑郁症的慢性疼痛的疗效。
Am J Ther. 2003 Sep-Oct;10(5):318-23. doi: 10.1097/00045391-200309000-00003.
4
Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial.文拉法辛与丙咪嗪治疗疼痛性多发性神经病的随机对照试验
Neurology. 2003 Apr 22;60(8):1284-9. doi: 10.1212/01.wnl.0000058749.49264.bd.
5
The association of irritable bowel syndrome and somatization disorder.肠易激综合征与躯体化障碍的关联。
Ann Clin Psychiatry. 2001 Mar;13(1):25-30. doi: 10.1023/a:1009060731057.
6
Gabapentin leads to remission of somatoform pain disorder with major depression.加巴喷丁可使伴有重度抑郁症的躯体形式疼痛障碍得到缓解。
Pharmacopsychiatry. 1999 Nov;32(6):255-7. doi: 10.1055/s-1999-7958.
Zotero 插件